Ensysce Biosciences Inc (NASDAQ: ENSC) Drops -5.43% Over A Month, But Analysts Still See Upside Potential

Ensysce Biosciences Inc (NASDAQ:ENSC) currently has a daily average trading volume of 1.56M but it saw 1676760 shares traded in last market. With a market cap of 5.44M USD, the company’s current market price of $3.31 came falling about -9.81 while comparing to the previous closing price of $3.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.67 and as low as $1.62. In the recent trading on the day, stock has struck highest price mark of $3.02 while lowest mark touched by it was $3.38.

Taking a look at 20-day trading activity of Ensysce Biosciences Inc (ENSC) gives us an average price of $2.33, while its current price level is -77.44% below from 52-week high level whereas it is 104.32% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.80 while that of 200 days or SMA-200 reads an average of $5.90. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.68% during that period while stretching the period over a month that decreases to 16.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 56.20 which implies that the stock is in neutral territory.

Over the week, ENSC’s stock price is moving 76.06% up while it is -5.43% when we observe its performance for the past one month. Year-to-date it is -59.34% down and over the past year, the stock is showing a downside performance of -59.21%.

Currently, Ensysce Biosciences Inc’s total number of outstanding shares is 1.64M with 0.63% of that held by the insiders while 8.56% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -215.38% and return on equity (ROE) at -471.82%. It has a 0.16 of forward P/E ratio. Stock’s beta reads 0.91. Stock has a price to book (P/B) ratio of 1.21 while price to sale or P/S ratio amounts to 1.04. Its return on asset (ROA) is -192.33% on average.